StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting
Regeneron Pharmaceuticals (REGN) found itself in the glare of unwelcome publicity when the U.S. Department of Justice (DOJ) announced it had filed a complaint accusing the biotech giant of fraudulently reporting the price of Eylea® (aflibercept), the …